Public Joint-Stock Company "Pharmsynthez" Share · RU000A0JR514 (MISX) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of Public Joint-Stock Company "Pharmsynthez"

No Price

Closing Price MISX 01.05.2026: 2,87 RUB

01.05.2026 15:32

Current Prices from Public Joint-Stock Company "Pharmsynthez"

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
MOEX	LIFE.ME	RUB	01.05.2026 15:32	2,87 RUB	0,005 RUB +0,17 %

Share Float & Liquidity

Free Float 28,56 %

Shares Float 85,97 M

Shares Outstanding 301,01 M

Company Profile for Public Joint-Stock Company "Pharmsynthez" Share

PJSC Pharmsynthez, a pharmaceutical company, researches, manufactures, and distributes officinal and generic active pharmaceutical ingredients in Russia and CIS countries. The company offers officinal medicines, including Neovir, Segidrin, Fenasid, and Penkrofton that are used in oncology, gynecology, treatment of immune deficiencies, and tuberculosis. Public Joint-Stock Company 'Pharmsynthez' has partnership with HiFiBiO Therapeutics Inks for the clinical development and commercialization of its SARS-CoV-2 neutralizing antibody in Russia. Public Joint-Stock Company 'Pharmsynthez' was founded in 1996 and is based in St. Petersburg, Russia.